Sorry to hear that Jase.
Yes just doing the same as the T cell therapies, but with no safety issues is enough. And how many $10's billions do T cell therapies make each year?
But as the patient produces their own antibodies, there's also the theory that they will be more effective and more on-demand. Also patients are less likely to build a resistance to the treatment.
The evidence so far is that B cells are looking far superior to T cell therapies. And T cell therapies are a very valuable and growing market - which B cells could wipe out in a flash.
The value of imu's product is potentially seriously big.
cheers
Sorry to hear that Jase. Yes just doing the same as the T cell...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 969572 | 8 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
